Publication | Closed Access

Pirfenidone inhibits epithelial-mesenchymal transition and pulmonary fibrosis in the rat silicosis model

Epithelial-mesenchymal TransitionAntifibrotic TherapyFibrosisInflammatory Lung DiseaseRat Silicosis ModelMedicinePathologyPulmonary PharmacologyPulmonary FibrosisCytoskeletonPharmacologyCell BiologyPulmonary Disease